Article info
Review
Progressive supranuclear palsy: diagnosis and management
- Correspondence to Dr James B Rowe, University of Cambridge Department of Clinical Neurosciences, Cambridge, Cambridgeshire, UK; james.rowe{at}mrc-cbu.cam.ac.uk
Citation
Progressive supranuclear palsy: diagnosis and management
Publication history
- Accepted April 13, 2021
- First published July 2, 2021.
Online issue publication
January 10, 2022
Article Versions
- Previous version (10 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Other content recommended for you
- Fifty years of progressive supranuclear palsy
- Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study
- Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes
- Neuronal network disintegration: common pathways linking neurodegenerative diseases
- Progressive supranuclear palsy
- Improving the diagnostic accuracy in parkinsonism: a three-pronged approach
- Parkinson's disease: chameleons and mimics
- Progressive supranuclear palsy (Steele-Richardson-Olszewski disease)
- DIAGNOSIS AND MANAGEMENT OF ATYPICAL PARKINSONIAN SYNDROMES